Charles Wykoff, MD, PhD
Disclosures: Consultant/Advisor-Acucela|Consultant/Advisor-Adverum|Consultant/Advisor-Aerpio|Consultant/Advisor-Alimera Sciences|Consultant/Advisor-Allegro|Consultant/Advisor-Allergan|Consultant/Advisor-Apellis|Consultant/Advisor-Bayer Corporation|Consultant/Advisor-Chengdu Kanghong|Consultant/Advisor-Clearside Biomedical|Consultant/Advisor-DORC|Consultant/Advisor-EyePoint|Consultant/Advisor-Genentech/Roche|Consultant/Advisor-Iveric Bio|Consultant/Advisor-Kodiak|Consultant/Advisor-Novartis|Consultant/Advisor-ONL Therapeutics|Consultant/Advisor-Oxurion|Consultant/Advisor-PolyPhotonix|Consultant/Advisor-Recens Medical|Consultant/Advisor-Regeneron|Consultant/Advisor-RegenxBio|Consultant/Advisor-Santen|Consultant/Advisor-Takeda|Research Grant-Adverum|Research Grant-Aerie Pharmaceuticals|Research Grant-Aerpio|Research Grant-Allergan|Research Grant-Apellis|Research Grant-Chengdu Kanghong|Research Grant-Clearside Biomedical|Research Grant-Gemini Therapeutics|Research Grant-Genentech/Roche|Research Grant-Graybug Vision|Research Grant-IONIS Pharmaceuticals|Research Grant-Iveric Bio|Research Grant-Kodiak|Research Grant-Neurotech|Research Grant-Novartis|Research Grant-Opthea|Research Grant-Outlook Therapeutics|Research Grant-Recens Medical|Research Grant-Regeneron|Research Grant-RegenxBio|Research Grant-Samsung|Research Grant-Santen|Research Grant-Xbrane Biopharma|Speakers Bureau-Regeneron
No Bio Available.